What is Alamar Biosciences 's change in AR?

Alamar Biosciences (ALMR) reported change in AR of $6.85M in Q1 2026.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

Alamar Biosciences ALMR Change in AR

Change in AR at other companies

Lineage, Inc.LINE

$32M+33.3%

FCF

FirstCash HoldingsFCFS

$2.42M+213%

SaiaSAIA

$46.95M+61.2%

Globus MedicalGMED

$13.4M+159%

GlaukosGKOS

$12.46M+1.2%

Deckers Outdoor CorporationDECK

-$22.81M-177%

Other financials

Income statement

See full

Revenue$26.0M+98.9%

Gross profit$14.5M+126%

Operating income-$12.3M-44.4%

Net income-$21.3M-178%

EPS (diluted)-$1.74-156%

Balance sheet

See full

Cash & equivalents$64.6M—

Total debt$30.6M—

Total equity-$178.1M—

Total assets$186.5M—

Cash flow

See full

Operating cash flow-$20.3M-55.7%

CapEx$600.0K+8.3%

Free cash flow-$20.9M-53.8%

Valuation

See full

Market cap$1.52B—

Enterprise value$1.49B—

Returns & leverage

See full

Debt / equity-0.2×—

Current ratio5.9×—

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alamar Biosciences 's change in AR?: Alamar Biosciences (ALMR) reported change in AR of $6.85M in Q1 2026.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.